Press release
Rising Prevalence Of Chronic Diseases Fuels Growth In The Biosimilar Monoclonal Antibodies Market: Critical Driver Shaping the Biosimilar Monoclonal Antibodies Market in 2025
Biosimilar Monoclonal Antibodies
_x000D_
Biosimilar Monoclonal Antibodies Market Size Valuation Forecast: What Will the Market Be Worth by 2025?_x000D_
In recent times, the biosimilar monoclonal antibodies market size has experienced swift expansion. Projected growth estimates suggest a rise from $8.04 billion in 2024 to $9.25 billion in 2025, a compound annual growth rate (CAGR) of 15.1%. Several factors have contributed to this growth during the historical period, including the expiration of patents, increased awareness of biosimilars, government-driven initiatives, heightened investment from pharmaceutical corporations, and the growing acceptance of biosimilars by medical professionals and patients._x000D_
_x000D_
Biosimilar Monoclonal Antibodies Market Size Forecast: What's the Projected Valuation by 2029?_x000D_
In the following years, it's anticipated that the biosimilar monoclonal antibodies market will experience significant growth, ultimately reaching a value of $12.79 billion in 2029, with a compound annual growth rate (CAGR) of 8.5%. This projected growth over the forecast period is due to a variety of factors, including an increase in biologic spending, an expanded biosimilar portfolio, personalized biosimilar therapies, and a growing public curiosity in biosimilars. Other anticipated trends during this period include the development of novel therapies, individualized biosimilars, collaborative ventures and partnerships, the introduction of biosimilar auto injection instruments, and bio-improved iterations._x000D_
_x000D_
View the full report here: _x000D_
https://www.thebusinessresearchcompany.com/report/biosimilar-monoclonal-antibodie-global-market-report_x000D_
_x000D_
What Are the Drivers Transforming the Biosimilar Monoclonal Antibodies Market?_x000D_
The increase in cases of chronic illnesses is predicted to fuel the market for biosimilar monoclonal antibodies. These antibodies are utilized in the management of chronic diseases like cancer, autoimmune disorders, and rheumatoid arthritis. In cancer care, monoclonal antibody biosimilars such as trastuzumab, bevacizumab, and rituximab are commonly used. Additionally, the rate of cancer occurrence continues to rise annually. As per the data released by the Centers for Disease Control and Prevention (CDC), a public health body in the US, in February 2024, an escalating number of US individuals are living with multiple chronic conditions - 42% with two or more, and 12% with five or more. Hence, the surge in chronic illnesses is expected to propel the biosimilar monoclonal antibodies market's expansion._x000D_
_x000D_
Get your free sample here:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=3412&type=smp_x000D_
_x000D_
What Long-Term Trends Will Define the Future of the Biosimilar Monoclonal Antibodies Market? _x000D_
Key players in the biosimilar monoclonal antibodies market are prioritizing the development of economical biosimilar therapies to stay ahead in the competition. These medical biologics, which closely resemble pre-approved reference monoclonal antibodies, are developed to provide inexpensive treatment alternatives for numerous diseases, such as cancer and autoimmune disorders. Take for example, Pfizer, a pharmaceutical firm based in the U.S., rolled out Abrilada, a biosimilar to AbbVie's Humira (adalimumab), in 2022. Abrilada has shown similar efficacy and safety to its original counterpart while offering substantial cost reductions for both patients and healthcare systems. It also enjoys advantages of a simplified approval process and strong manufacturing capabilities, thus improving patient access to crucial treatments. This development is indicative of a wider industry trend focusing on tackling escalating healthcare expenses without compromising on the quality of therapy options available to patients._x000D_
_x000D_
Which Segments in the Biosimilar Monoclonal Antibodies Market Offer the Most Profit Potential?_x000D_
The biosimilar monoclonal antibodies market covered in this report is segmented - _x000D_
_x000D_
1) By Type: Synthetic Chemicals, Biopharmaceuticals, Other Types_x000D_
2) By Compound: Infliximab, Rituximab, Abciximab, Trastuzumab, Adalimumab, Bevacizumab_x000D_
3) By Application: Chronic & Autoimmune Diseases, Oncology, Other Applications_x000D_
_x000D_
Subsegments:_x000D_
1) By Synthetic Chemicals: Small Molecule Drugs, Chemical Synthesis Products_x000D_
2) By Biopharmaceuticals: Monoclonal Antibodies, Recombinant Proteins, Vaccines, Other Biopharmaceuticals_x000D_
3) By Other Types: Antibody-Drug Conjugates, Fusion Proteins, Biosimilars Of Other Biologics_x000D_
_x000D_
_x000D_
Tailor your insights and customize the full report here:_x000D_
https://www.thebusinessresearchcompany.com/customise?id=3412&type=smp_x000D_
_x000D_
Which Firms Dominate the Biosimilar Monoclonal Antibodies Market by Market Share and Revenue in 2025?_x000D_
Major companies operating in the biosimilar monoclonal antibodies market include Pfizer Inc., Novartis AG, AbbVie Inc., Coherus BioSciences, Biocon Limited, Amgen Inc., Boehringer Ingelheim International GmbH, Celltrion Inc., BioXpress Therapeutics SA, Intas Pharmaceuticals Limited, Genor BioPharma Co. Ltd., BIOCAD, Dr. Reddy's Laboratories Ltd., 3SBio Inc., Reliance Life Sciences, Hisun Pharmaceuticals, Celgen Biopharmaceuticals, Torrent Pharmaceuticals Ltd., Cadila Healthcare Ltd., Shanghai Henlius Biotech Inc., Teva Pharmaceutical Industries Ltd., Alvotech, Xentria Inc., Lazuline Biotech Private Limited, Epygen Biotech Pvt Ltd., Mabpharm Limited, Qilu Pharmaceutical Co. Ltd., Chiatai Tianqing Pharmaceutical Group Co. Ltd., YL Biologics Ltd., Aprogen Biologics, UNDBIO Co Ltd., Samsung Bioepis Co. Ltd., ISU Abxis Corp., Bio-Rad Laboratories Inc. _x000D_
_x000D_
Which Regions Offer the Highest Growth Potential in the Biosimilar Monoclonal Antibodies Market?_x000D_
The countries covered in the biosimilar monoclonal antibodies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada._x000D_
_x000D_
Purchase the full report today:_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3412_x000D_
_x000D_
"This Report Supports:_x000D_
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions._x000D_
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning._x000D_
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks._x000D_
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Prevalence Of Chronic Diseases Fuels Growth In The Biosimilar Monoclonal Antibodies Market: Critical Driver Shaping the Biosimilar Monoclonal Antibodies Market in 2025 here
News-ID: 4153465 • Views: …
More Releases from The Business Research Company
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory.
Projected Expansion of the Wire Arc Additive Manufacturing Cell Market
The wire arc additive manufacturing cell…
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry.
Projected Market Growth and Size of…
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future.
Projected Expansion and Market Size of…
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry.
Projected Market Value and Growth of the Transient Elastography Market
The transient elastography market is…
More Releases for Biosimilar
Interchangeable Biosimilar Humira Market Share Driven by Biologic Therapy Adopti …
Interchangeable Biosimilar Humira Market
The global market for Interchangeable Biosimilar Humira was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-33I15005/Global_Interchangeable_Biosimilar_Humira_Market_Research_Report_2023
The Interchangeable Biosimilar Humira Market is experiencing significant market growth as healthcare providers and patients increasingly adopt biosimilar therapies for autoimmune and inflammatory conditions. Market trends indicate rising…
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Biosimilar Market Treating More for Less: The Booming Infliximab Biosimilar Mark …
Infliximab Biosimilar Market worth $ XX Million by 2030 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Infliximab Biosimilar Market- by Application (Crohn's Disease, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Plaque Psoriasis and Others), End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Direct Distribution Channels), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
Get…
Biosimilar Monoclonal Antibodies Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Biosimilar Monoclonal Antibodies Market by Product (infliximab, trastuzumab, rituximab, adalimumab, bevacizumab, cetuximab, ranibizumab, denosumab, eculizumab, and other pipeline products), Indication (oncology, inflammatory & autoimmune disorders, chronic diseases, blood disorders, and other indications), Clinical Trial/Pipeline Analysis, Future Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
The Biosimilar Monoclonal Antibodies Market Size is valued at 5.02…
Infliximab Biosimilar Insight, 2022 | DelveInsight
DelveInsight's, "Infliximab Biosimilar Insight, 2022" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Interested to know more about the functioning of…
